Brown, DE
Dan B. Brown, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20090215744 | Solid Formulations - The present invention is directed to solid formulations of the pharmaceutical compound 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine as well as preparations, and pharmaceutical uses thereof. | 08-27-2009 |
20110237568 | CRYSTALLINE FORMS - 11-piperazin- | 09-29-2011 |
Daniel Brown, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20080287418 | Extended Release Compositions and Methods for Their Manufacture - Extended release formulations of quetiapine and its pharmaceutically salts, and methods for manufacture of the formulations, may include the use of polymers selected for their physical and chemical characteristics. The formulations may include polymers selected to cause solid dosage forms of the formulations to conform to preselected quetiapine release criteria. The formulations may include non-polymer materials that may affect quetiapine release. | 11-20-2008 |
20110319383 | Extended Release Formulations Comprising Quetiapine and Methods for Their Manufacture - The present invention relates to extended release formulations of quetiapine and its pharmaceutically acceptable salts. The formulations comprise polymers, preferably hydroxypropyl methylcellulose of different viscosities, selected to cause the formulations to conform to preselected quetiapine release profiles. A process for the manufacture of said formulations is also disclosed. | 12-29-2011 |
Dean G. Brown, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20090012127 | Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor Modulators - Compounds of Formula (I) wherein E, A and R1 are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same. | 01-08-2009 |
20090192169 | Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators - Compounds of Formula I: | 07-30-2009 |
Jesse Paul Brown, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20110247743 | AUTOMATED BIAS-PLY PREPARATION DEVICE AND PROCESS - A material preparation device is provided. The material preparation device includes a bias-ply assembly, a feedstock assembly and an application head. The bias-ply assembly is configured to pass a bias-ply backing material along a first path. The feedstock assembly is configured to pass a feedstock along a second path that crosses the first path at a select angle. The feedstock includes resin pre-impregnated fiber reinforced material (pre-preg) having the fibers at a first orientation relative to an edge of the feedstock. The application head is configured to transfer the pre-preg from the feedstock to the bias-ply backing material at a location where the first path crosses the second path to form a bias-ply with the fibers of the pre-preg having a second different orientation relative to an edge of the formed bias-ply. | 10-13-2011 |
Karen Lavern Brown, Bear, DE US
Patent application number | Description | Published |
---|---|---|
20140316982 | System and Method for Electronic Bill Pay and Presentment - A system and method is disclosed enabling a customer payor to make payment to a payee in a networked environment using a credit card, revolving credit, or other credit account. The payment system may provide for online receipt and review of bills, and may allow a customer payor to optionally select one or more alternative secondary accounts for payment in the event that payment cannot be made from a primary credit account. The secondary account may be another credit account, a checking account, a brokerage account, or another type of account. Actual payment may be accomplished by electronic settlement of a credit transaction, electronic funds transfer, or by printing and physically delivering a paper check. A customer payor using the system and method may receive notification concerning the success or failure of the transaction. | 10-23-2014 |
Michael Joseph Brown, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20150329659 | SOLUBLE VINYL FLUORIDE INTERPOLYMERS AND POLYMER BINDER SOLUTIONS - In a first aspect, an interpolymer includes polymer units derived from about 64 to about 75 mole percent vinyl fluoride and from about 25 to about 36 mole percent of at least two highly fluorinated monomers. A first highly fluorinated monomer provides the interpolymer a side chain of at least one carbon atom and the interpolymer is soluble in a solvent selected from the group consisting of dimethyl acetamide, N-methyl pyrrolidone, dimethyl sulfoxide, dimethyl formamide and mixtures thereof. | 11-19-2015 |
20150332805 | ELECTRODE COMPOSITIONS AND ENERGY STORAGE DEVICES - In a first aspect, an electrode composition includes an electroactive material and an interpolymer including polymer units derived from about 64 to about 75 mole percent vinyl fluoride and from about 25 to about 36 mole percent of at least two highly fluorinated monomers. A first highly fluorinated monomer provides the interpolymer a side chain of at least one carbon atom. | 11-19-2015 |
Patricia Brown, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20110045977 | Compositions for treating water systems - The present invention relates to treatment of water, and more specifically to treatment of water using a stable formulation of polyhexamethylene biguanide (PHMB) and a liquid or solid zinc salt for the application and prevention algae in recirculated and stagnant water systems. The invention also encompasses methods of treating water that already contains PHMB. | 02-24-2011 |
20130217575 | COMPOSITIONS FOR TREATING WATER SYSTEMS - The present invention relates to treatment of water, and more specifically to treatment of water using a stable formulation of polyhexamethylene biguanide (PHMB) and a liquid or solid zinc salt for the application and prevention algae in recirculated and stagnant water systems. The invention also encompasses methods of treating water that already contains PHMB. | 08-22-2013 |
Peter A Brown, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20130225023 | Dielectric Fluids Comprising Polyol Esters - Dielectric fluids are provided, the dielectric fluids comprising a mixture of polyol esters derived from a reaction of a) a polyol comprising pentaerythritol, trimethylolpropane, neopentyl glycol, or combinations thereof, and b) a mixture of fatty acid esters derived from a high oleic soybean oil comprising fatty acid moieties, wherein the high oleic soybean oil has a C18:1 content of greater than 65% of the fatty acid moieties in the oil, and a combined C18:2 and C18:3 content of less than 20% of the fatty acid moieties in the oil. Also provided are electrical apparatuses comprising the dielectric fluids, and processes for preparing the mixtures of polyol esters. | 08-29-2013 |
20130337249 | Insulating Material Comprising Nonwoven Webs - Insulating materials are provided, the insulating materials comprising a nonwoven web comprising a plurality of continuous spunbonded polyester bicomponent fibers. Each of the plurality of bicomponent fibers comprises a) from about 20% by weight to about 80% by weight of poly(ethylene terephthalate) in a core, and b) from about 80% by weight to about 20% by weight of poly(trimethylene terephathalate) in a sheath surrounding the core, wherein the amounts in percent by weight are based on the total weight of each of the plurality of bicomponent fibers. Also provided are electrical apparatuses comprising the insulating materials and a dielectric fluid, as well as a dielectric material comprising the nonwoven web impregnated with at least 10 weight percent of a dielectric fluid. | 12-19-2013 |
20130338335 | PREPARATION OF SULFONATED NAPHTHALENE POLYOXADIAZOLES POLYMERS - Described is the preparation of sulfonated polyoxadiazole polymers with a high degree of sulfonation and good flammability properties. The polymers are useful in articles such as fibers. | 12-19-2013 |
Scott Chang Brown, Hockessin, DE US
Patent application number | Description | Published |
---|---|---|
20130039858 | NIR MATERIALS AND NANOMATERIALS FOR THERANOSTIC APPLICATIONS - Novel fluorescent dye comprising metal oxide nanoparticles are prepared where the nanoparticles are as small as 3 nm or up to 7000 nm in diameter and where the dye is bound within the metal oxide matrix. In some embodiments the invention, novel dyes are covalently attached to the matrix and in other embodiments of the invention a dye is coordinate or ionic bound within the metal oxide matrix. A method for preparing the novel covalently bondable modified fluorescent dyes is presented. A method to prepare silica comprising nanoparticles that are 3 to 8 nm in diameter is presented. In some embodiments, the fluorescent dye comprising metal oxide nanoparticles are further decorated with functionality for use as multimodal in vitro or in vivo imaging agents. In other embodiments of the invention, the fluorescent dye comprising metal oxide nanoparticles provide therapeutic activity and incorporated therapeutic temperature monitoring. | 02-14-2013 |
20130108552 | NEAR-IR INDOCYANINE GREEN DOPED MULTIMODAL SILICA NANOPARTICLES AND METHODS FOR MAKING THE SAME | 05-02-2013 |
20130129633 | MULTIMODAL NANOPARTICLES FOR NON-INVASIVE BIO-IMAGING - Multimodal nanoparticles are nanoparticles containing contrast agents for PAT and one or more of luminescence imaging, x-ray imaging, and/or MRI. The multimodal nanoparticles can have a dielectric core comprising an oxide with a metal coating on the core. The particles can be metal speckled. The multimodal nanoparticles can be used for therapeutic purposes such as ablation of tumors or by neutron capture in addition to use as contrast agents for imaging. | 05-23-2013 |
Steven D. Brown, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20130261406 | METHOD FOR BUILDING AN ALGORITHM FOR CONVERTING SPECTRAL INFORMATION - A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid. | 10-03-2013 |